MedTrace Logo

Phenotypic and Genotypic Characterization of New-onset Type I Diabetes

NCT04007809 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 98

Last updated 2022-06-28

No results posted yet for this study

Summary

The goal of DIATAG study is the identification of biomarkers of T1D evolution in a pediatric cohort.

Conditions

  • Type1diabetes

Interventions

OTHER

Glucagon

Every patients will undergo stimulated C peptide test. Glucagon will be administered using intravenous route (0,03 mg/kg, max 1mg).

Sponsors & Collaborators

  • Fonds National de la Recherche Scientifique

    collaborator OTHER

  • BESPEED

    collaborator UNKNOWN

  • Université Catholique de Louvain

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
6 Months
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-15
Primary Completion
2022-08-15
Completion
2027-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04007809 on ClinicalTrials.gov